Carl Genberg
Technik-/Wissenschafts-/F&E-Leiter bei Ceragenix Corp.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Steven S. Porter | M | 73 |
Ceragenix Corp.
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | 22 Jahre |
Peter M. Elias | M | 81 |
Ceragenix Corp.
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | 20 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Russell L. Allen | M | 76 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | - |
Jeffrey S. Sperber | M | 59 |
Ceragenix Corp.
| - |
Michel Darnaud | M | 74 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | 5 Jahre |
Philippe J. C. Gastone | M | 69 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | 5 Jahre |
Alberto Bautista | M | 72 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | 5 Jahre |
Cheryl A. Hoffman-Bray | F | 66 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | 5 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 8 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Carl Genberg
- Persönliches Netzwerk